Sunday, December 2, 2018

Sun Pharma plunges 10% as SEBI plans to reopen insider trading case

Sun Pharma plunges 10% as SEBI plans to reopen insider trading case Sun Pharma, along with its Managing Director Dilip Shanghvi, and nine others had settled the insider trading probe, paying Rs 18 lakh against the settlement charges in 2017

from Moneycontrol Business News https://ift.tt/2Q9ybrR

No comments:

Post a Comment

Paras Defence shares soar 10% as Q2 net profit jumps 50% to Rs 14 crore

Paras Defence and Space Technologies shares surged following strong September quarter results, with net profit jumping 50% and revenue climb...